Xuting (Rebecca) Sheng, PhD

Genentech
South San Francisco, California, United States

Biomarker scientist supporting drug development in autoimmune diseases

Presentation(s):

• 0679: Inhibition of TGFb3 in Systemic Sclerosis Patients Does Not Result in TGFb Pathway Modulation in Skin Biopsies or Circulation

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Genentech: Employee (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing)